Editorial
. In these situations, more attention to PM may be needed in patients receiving intensive care, particularly those with immunocompromised status.
Unlike pulmonary aspergillosis, the clinical outcomes of PM have not improved significantly over the last decade, mainly because early diagnosis of PM is difficult and antifungal agents against Mucorales show limited activity [7] . Moreover, there are limited data differentiating computed tomography (CT) findings for PM from invasive pulmonary aspergillosis [9] . Although diagnostic methods for PM, such as fiber optic bronchoscopy with bronchoalveolar lavage or image-guided fine needle aspiration cytology, have been reported [10, 11] , the accurate diagnosis of PM in patients in the intensive care unit remains a challenge.
At present, early and accurate diagnosis of PM is a very important issue for improving the therapeutic effect. We 
Materials and Methods
This study was performed at the a tertiary-care teach- 
Results
Characteristics of PM patients and their underlying diseases are summarized in Table 1 . Of the nine patients, four were male. The median age was 64 years (range, 12 to 73 years). The underlying diseases at diagnosis of PM were hematologic malignancy (seven cases) and solid cancer (two cases). Three patients had diabetes mellitus, and nine patients had received chemotherapy prior to diagnosis of PM. PM was proven and probable in seven and two cases, respectively.
CT findings of PM are summarized in Table 2 . Unilateral involvement was shown in eight cases (89%), consolidation in eight cases (89%), and ground glass opacity in four cases. However, reverse halo sign was only shown in one case (11%). Fungal infections, such as invasive pulmonary aspergillosis or PM, suspected on CT by radiologists were present in three cases (33%). Four cases (44%) were suspected to have bacterial pneumonia on CT.
The mortality rate was 56% (five of nine cases) ( Table 3 
Discussion
The present study shows that PM is associated with high mortality rates, which might be improved in cases receiving surgical treatment. Moreover, TBLB might be an early and feasible tool for diagnosing PM in suspected critical patients.
Little is known about the clinical presentations of PM.
Most of the data showing clinical features of mucormycosis, including PM, has originated from case series and small-sized studies on specific patient groups such as patients with hematologic malignancies [5, 10] . Known clinical manifestations of PM are summarized as fol- lows: (1) underlying host risk factors were neutropenia, induction chemotherapy, hematopoietic stem cell transplantation with graft-versus-host disease, and lung transplantation [7] ; (2) the pathogenesis of the disease state was hyphal invasion of pulmonary blood vessels, which could result in hemorrhage, thrombosis, ischemia, and infarction of distal tissue [7, 13] ; (3) clinical characteristics were prolonged high-grade fever (>38°C), nonproductive cough, airway obstruction from endobronchial or tracheal lesions, massive hemoptysis; and (4) the mortality rate was 66% or higher, depending on the level of immunosuppression [6, 14] . To date, however, there is no clinical history specific for the diagnosis of PM.
It is typically difficult to suspect PM and make a diagnosis early because PM is characterized by non-specific clinical features and radiologic findings, a low culturepositive rate, and a lack of biologic markers [4] . There were several reports that CT findings useful for the diagnosis of PM were progressive, homogeneous lobar or multilobar consolidation; nodules or mass-like or wedgeshaped consolidation; and a halo sign of ground glass opacity surrounding a pulmonary nodule [15, 16] . On the other hand, Jung et al. [9] showed that the reverse halo for a definite diagnosis [12, 17] , although it had been reported that analysis of an adequate bronchoalveolar lavage specimen from fiber optic bronchoscopy was a useful diagnostic method [10] . Recently, Sharma et al.
[11] evaluated the role of fine needle aspiration cytology in the diagnosis of pulmonary infections in 42 immunocompromised patients and showed that it was a relatively reliable, safe, and rapid method of diagnosing pulmonary [20] , a widely used treatment for invasive pulmonary aspergillosis, which has a clinical presentation similar to that of PM. Therefore, at present, an early and accurate diagnosis is paramount in the treatment of PM.
The main treatment strategy for PM is immediate surgical resection of the infected lung, such as wedge resection, lobectomy, or pneumonectomy, in combination with antifungal agents. These treatments have been associated with lower mortality rates in many reported cases [21] [22] [23] .
Additionally, for medical therapy for PM, the only recommended antifungal agents are members of the polyene class, including amphotericin B deoxycholate and its lipid derivatives. Triazoles, posaconazole, isavuconazole, echinocandins, and combination therapy could be also considered [4] . In our study, two patients receiving surgical resection were alive after treatment. However, it may be considered that patients in good condition are more likely to receive surgery.
This report has limitations due to its retrospective and non-controlled nature. Long-term observational and interventional controlled studies are needed for more advanced knowledge of PM. Moreover, clinicians should be concerned with complications of TBLB, though there were no cases of pneumothorax nor hemorrhage in this study.
PM is an emerging invasive infection and is often fatal, and its successful treatment relies on a timely diagnosis.
TBLB can be an easy and useful technique for diagnosing PM in the intensive care unit.
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